Microcrystalline Cellulose Market, By Type of Source (Wood-Based, and Non-wood based), By End-User (Pharmaceutical, Food and Beverage, Cosmetics and Personal Care, and Others), By Region Analysis - Global Analysis and Industry Forecast Report Till 2030.

The Microcrystalline Cellulose Market is projected to grow from $399.9 million to $681.38 million, at a CAGR of 6.1% during the forecast period 2021-2030.

Microcrystalline cellulose can be referred to as partially depolymerized cellulose in the pure form prepared from cellulose precursors. There are various methods to produce microcrystalline cellulose such as acid hydrolysis, reactive extrusion, steam explosion, and enzyme-mediated synthesis. Microcrystalline cellulose has large-scale applications in the food and beverage, pharmaceutical, and personal care industries. In the food and beverage industry, microcrystalline cellulose is added to processed foods to create a creamy, smooth texture.

Microcrystalline cellulose is widely preferred as a pharmaceutical excipient in the pharmaceutical industry because of its high organic nature, low investment, and cost-effectiveness. This is leading the market all over the world.

Microcrystalline cellulose is a versatile and widely used ingredient in the pharmaceutical industry. Its manufacturing process involves the controlled breakdown of cellulose into tiny crystals, resulting in a fine powder with excellent flowability and compressibility. In pharmaceuticals, microcrystalline cellulose finds various uses, including as a binder, diluent, and disintegrant in tablet formulations. It improves the tablet's mechanical strength, facilitates drug release, and enhances stability. While generally considered safe and well-tolerated, some individuals may experience mild side effects such as bloating or gas due to its high fiber content. Overall, microcrystalline cellulose is a crucial component in the production of high-quality pharmaceutical formulations, contributing to their efficacy and patient compliance.

Market Dynamics:

Drivers:

The increasing application of microcrystalline cellulose in various industries is a major factor propelling the growth of the global microcrystalline cellulose market. For example, microcrystalline cellulose is used as a stabilizer, gelling agent, suspending agent, and anti-caking agent in beverages. It is also used as a cold and hot stabilizer in frozen foods, ice cream, and canned meats to improve the shelf life of these products. Additionally, Microcrystalline Cellulose is widely used in pharmaceuticals due to its tasteless, odorless, and chemically inert properties. These features of MCC are likely to propel the growth of this market.

Restraints:

The lack of universal guidelines related to the application of microcrystalline cellulose is expected to restrain the market growth during the forecast period. Every country has different guidelines regarding the use and application of microcrystalline cellulose. Major players find it difficult to cope with these country-specific regulations, which in turn hinders investments in the microcrystalline cellulose industry, thereby restraining market growth.

Opportunities:

Growing disposable income and rising health awareness among people are fueling the growth of food & beverage and pharmaceutical industries in emerging economies and various sub-regions such as China, India, South Africa, Indonesia, Brazil, and the Association of Southeast Asian Nations etc. These factors are contributing to bringing many opportunities in this market.

Key Players:

• DowDupont Inc.

• FMC Corporation

• Asahi Kasei Chemicals Corporation

• Accent Microcell Pvt. Ltd

• JRS PHARMA GmbH and Co. KG

• Ming Tai Chemical Co. Ltd

• Foodchem International Corporation

• Maple Biotech Pvt. Ltd.

• Chemfield Cellulose

• NB Entrepreneurs

• Cellutech Pharma

• Quadra Chemicals

• Ankit Pulps

• Roquette

• Sigachi Industries Pvt. Ltd

• LinghuXinwang Chemical Co., Ltd

• Amishi Drugs And Chemicals Pvt Ltd

• ASHOK CHEM–PHARMA

• Anhui Shanhe Pharmaceutical Excipients Co., Ltd.

• DFE Pharma

• Weiming Pharmaceutical MFG. Co., Ltd

• Pharmatrans-Sanaq AG

Market Segmentation:

Microcrystalline Cellulose Market, By Type of Source

• Wood-Based

• Non-wood based

Microcrystalline Cellulose Market, By End-User

• Pharmaceutical

• Food and Beverage

• Cosmetics and Personal Care

• Others

Microcrystalline Cellulose Market, By Region Type

• North America 

• Europe 

• Asia-Pacific 

• LAMEA 

Regional Analysis:

North America held the dominant position in terms of revenue in the global microcrystalline cellulose market in 2021, among the regions. This is due to the steady growth of the food and pharmaceutical industries as microcrystalline cellulose is in high demand in the pharmaceutical sector and is extensively used as a functional ingredient in food and beverages. Moreover, the rising demand for low-fat foods owing to rising obese population in the region is a factor expected to support the market growth during the forecast period.

The Asia Pacific microcrystalline cellulose market is expected to grow at the fastest CAGR from 2021 to 2030. This is a growth factor for the region due to economic recovery and rising employment rates, which in turn support growth. In addition, the Chinese microcrystalline cellulose market accounted for the largest market share, while the Indian microcrystalline cellulose market was the fastest-growing market in the Asia Pacific.

Scope of the report:

User

Tab Content